Advertisement

Molecular Medicine

, Volume 14, Issue 7–8, pp 412–421 | Cite as

p16INK4a Gene Promoter Hypermethylation in Mucosa as a Prognostic Factor for Patients with Colorectal Cancer

  • Yvonne Wettergren
  • Elisabeth Odin
  • Staffan Nilsson
  • Göran Carlsson
  • Bengt Gustavsson
Research Article

Abstract

Low gene expression of folylpolyglutamate synthase (FPGS) in colorectal mucosa correlates with low folate levels and poor survival of colorectal cancer (CRC) patients. Because gene-specific hypermethylation is affected by the folate level, the hypermethylation status in mucosa may also be linked to clinical outcome of CRC patients. The tumor suppressor gene p16INK4a (p16) regulates the cell cycle and angiogenic switch. In human neoplastic tissues, the main mechanism of p16 inactivation is promoter methylation. The aim of the study was to determine whether hypermethylation of the p16 promoter could be detected in mucosa of CRC patients (n = 181) and to analyze if hypermethylation was related to survival. The relation between p16 hypermethylation and expression of FPGS and two other folate-associated genes, reduced folate carrier 1 (RFC-1), and thymidylate synthase (TS), was analyzed (n = 63). The results showed that p16 was hypermethylated in 65 (36%) of the mucosa samples and that hypermethylation was age-related (P = 0.029). After adjustment for known risk factors, Cox regression analysis showed that Dukes’ A–C patients with p16 hypermethylation in mucosa had an increased risk of cancer-related death (hazard ratio = 2.9, P = 0.007) and shorter disease-free survival (hazard ratio = 2.5, P = 0.015) compared with patients with no p16 hypermethylation. RFC-1 and FPGS gene expression levels were significantly correlated in patients lacking p16 hypermethylation in mucosa (P = 0.0003), but not at all correlated in patients having hypermethylation in mucosa (P = 1.0). In conclusion, p16 hypermethylation in mucosa of CRC patients was identified as an independent prognostic parameter for cancer-specific survival as well as an independent predictor of DFS. The results suggest that there might be a connection between folate-associated gene expression and p16 methylation status.

Notes

Acknowledgments

We greatly acknowledge the excellent technical skills of Marie Martinsson, Marianne Akerström, and Jaqueline Flach. We are thankful to Hillevi Björkqvist for collecting surgical tissue samples and to Lena Munro, MarieLouise Jakobsson, and Birgitta Sjöberg for collecting clinical data. This work was supported by grants from the Swedish Cancer Society (05-0213), Göteborg University Foundation (ALFGBG2654), Assar Gabrielsson Foundation for Cancer Research (2001-74/BMP), Gustaf V Jubilee Clinic Foundation for Cancer Research (2001:117), and Ingabritt and Arne Lundberg Foundation (2005/96).

References

  1. 1.
    Cancer incidence in Sweden 2006 (2007). Stockholm. Socialstyrelsen.Google Scholar
  2. 2.
    Ngoi SS, Staiano-Coico L, Godwin TA, Wong RJ, DeCosse JJ. (1990) Abnormal DNA ploidy and proliferative patterns in superficial colonic epithelium adjacent to colorectal cancer. Cancer. 66:953–9.CrossRefGoogle Scholar
  3. 3.
    Wang QA, Gao H, Wang YH, Chen YL. (1991) The clinical and biological significance of the transitional mucosa adjacent to colorectal cancer. Jpn. J. Surg. 21:253–61.CrossRefGoogle Scholar
  4. 4.
    Feng M, Pei F, Yang G, Mao Z, Wang S. (2000) Expression of p53 and p21 protein in transitional mucosa adjacent to rectal carcinoma and its clinical implication. J. Tongji. Med. Univ. 20:220–1.CrossRefGoogle Scholar
  5. 5.
    Kuniyasu H et al. (2000) Induction of angiogenesis by hyperplastic colonic mucosa adjacent to colon cancer. Am. J. Pathol. 157:1523–35.CrossRefGoogle Scholar
  6. 6.
    Kuniyasu H et al. (2001) Prospective study of ki-67 labeling index in the mucosa adjacent to cancer as a marker for colorectal cancer metastasis. J. Exp. Clin. Cancer Res. 20:543–8.PubMedGoogle Scholar
  7. 7.
    Barrier A et al. (2005) Colon cancer prognosis prediction by gene expression profiling. Oncogene. 24:6155–64.CrossRefGoogle Scholar
  8. 8.
    Odin E et al. (2006) Expression and clinical significance of methylenetetrahydrofolate reductase in patients with colorectal cancer. Clin. Colorectal Cancer. 5:344–9.CrossRefGoogle Scholar
  9. 9.
    Barrier A et al. (2007) Prognosis of stage II colon cancer by non-neoplastic mucosa gene expression profiling. Oncogene. 26:2642–8.CrossRefGoogle Scholar
  10. 10.
    van Engeland M et al. (2003) Effects of dietary folate and alcohol intake on promoter methylation in sporadic colorectal cancer: The Netherlands cohort study on diet and cancer. Cancer Res. 63: 3133–7.PubMedPubMedCentralGoogle Scholar
  11. 11.
    Jiang Q et al. (2005) Diets, polymorphisms of methylenetetrahydrofolate reductase, and the susceptibility of colon cancer and rectal cancer. Cancer Detect. Prev. 29:146–54.CrossRefGoogle Scholar
  12. 12.
    Odin E et al. (2003) Altered gene expression of folate enzymes in adjacent mucosa is associated with outcome of colorectal cancer patients. Clin. Cancer Res. 9:6012–9.PubMedGoogle Scholar
  13. 13.
    Sharpless NE. (2005) INK4a/ARF: a multifunctional tumor suppressor locus. Mutat. Res. 576: 22–38.CrossRefGoogle Scholar
  14. 14.
    Alhaja E et al. (2004) Anti-migratory and anti-angiogenic effect of p16: A novel localization at membrane ruffles and lamellipodia in endothelial cells. Angiogenesis. 7:323–33.CrossRefGoogle Scholar
  15. 15.
    Reynolds PA et al. (2006) Tumor suppressor p16INK4A regulates polycomb-mediated DNA hypermethylation in human mammary epithelial cells. J. Biol. Chem. 281:24790–802.CrossRefGoogle Scholar
  16. 16.
    Waki T, Tamura G, Sato M, Motoyama T. (2003) Age-related methylation of tumor suppressor and tumor-related genes: An analysis of autopsy samples. Oncogene. 22:4128–33.CrossRefGoogle Scholar
  17. 17.
    Issa JP, Ahuja N, Toyota M, Bronner MP, Brentnall TA. (2001) Accelerated age-related cpg island methylation in ulcerative colitis. Cancer Res. 61:3573–7.PubMedGoogle Scholar
  18. 18.
    Rashid A, Shen L, Morris JS, Issa JP, Hamilton SR. (2001) Cpg island methylation in colorectal adenomas. Am. J. Pathol. 159:1129–35.Google Scholar
  19. 19.
    Trzeciak L, Hennig E, Kolodziejski J, Nowacki M, Ostrowski J. (2001) Mutations, methylation and expression of cdkn2a/p16 gene in colorectal cancer and normal colonic mucosa. Cancer Lett. 163:17–23.CrossRefGoogle Scholar
  20. 20.
    Herman JG et al. (1995) Inactivation of the cdkn2/p16/mts1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res. 55:4525–30.Google Scholar
  21. 21.
    Hsieh CJ et al. (1998) Hypermethylation of the p16INK4a promoter in colectomy specimens of patients with long-standing and extensive ulcerative colitis. Cancer Res. 58:3942–5.PubMedGoogle Scholar
  22. 22.
    Jang TJ, Kim DI, Shin YM, Chang HK, Yang CH. (2001) p16(INK4a) promoter hypermethylation of non-tumorous tissue adjacent to gastric cancer is correlated with glandular atrophy and chronic inflammation. Int. J. Cancer. 93:629–34.CrossRefGoogle Scholar
  23. 23.
    Liang JT et al. (1999) Hypermethylation of the p16 gene in sporadic T3N0M0 stage colorectal cancers: Association with DNA replication error and shorter survival. Oncology. 57:149–56.CrossRefGoogle Scholar
  24. 24.
    Wiencke JK et al. (1999) Aberrant methylation of p16INK4a in anatomic and gender-specific subtypes of sporadic colorectal cancer. Cancer Epidemiol. Biomarkers Prev. 8:501–6.PubMedGoogle Scholar
  25. 25.
    Schneider-Stock R et al. (2003) Differences in loss of p16ink4 protein expression by promoter methylation between left- and right-sided primary colorectal carcinomas. Int. J. Oncol. 23:1009–13.PubMedGoogle Scholar
  26. 26.
    Ahuja N, Li Q, Mohan AL, Baylin SB, Issa JP. (1998) Aging and DNAmethylation in colorectal mucosa and cancer. Cancer Res. 58:5489–94.PubMedGoogle Scholar
  27. 27.
    Lin SY et al. (2004) Promoter cpg methylation of tumor suppressor genes in colorectal cancer and its relationship to clinical features. Oncol Rep. 11:341–8.PubMedGoogle Scholar
  28. 28.
    Zhang J, Lai MD, Chen J. (1999) Methylation status of p16 gene in colorectal carcinoma and normal colonic mucosa. World J. Gastroenterol. 5:451–4.CrossRefGoogle Scholar
  29. 29.
    Gonzalez-Quevedo R et al. (2004) Differential impact of p16 inactivation by promoter methylation in non-small cell lung and colorectal cancer: Clinical implications. Int. J. Oncol. 24:349–55.PubMedGoogle Scholar
  30. 30.
    Terpstra OT, van Blankenstein M, Dees J, Eilers GA. (1987) Abnormal pattern of cell proliferation in the entire colonic mucosa of patients with colon adenoma or cancer. Gastroenterology. 92:704–8.CrossRefGoogle Scholar
  31. 31.
    Chen LC et al. (2004) Alteration of gene expression in normal-appearing colon mucosa of apc(min) mice and human cancer patients. Cancer Res. 64:3694–700.CrossRefGoogle Scholar
  32. 32.
    Hao CY et al. (2005) Alteration of gene expression in macroscopically normal colonic mucosa from individuals with a family history of sporadic colon cancer. Clin. Cancer Res. 11:1400–7.CrossRefGoogle Scholar
  33. 33.
    Nuovo GJ, Nakagawa H, Sotamaa K, Chapelle Ade L. (2006) Hypermethylation of the mlh1 promoter with concomitant absence of transcript and protein occurs in small patches of crypt cells in unaffected mucosa from sporadic colorectal carcinoma. Diagn. Mol. Pathol. 15:17–23.CrossRefGoogle Scholar
  34. 34.
    Badvie S et al. (2006) A “Field change” Of inhibited apoptosis occurs in colorectal mucosa adjacent to colorectal adenocarcinoma. J. Clin. Pathol. 59:942–6.CrossRefGoogle Scholar
  35. 35.
    Polley AC et al. (2006) Proteomic analysis reveals field-wide changes in protein expression in the morphologically normal mucosa of patients with colorectal neoplasia. Cancer Res. 66:6553–62.CrossRefGoogle Scholar
  36. 36.
    Hamilton SR, Aaltonen LA, editors. (2000) Pathology and Genetics of Tumours of the Digestive System. Lyon: IARC Press. 314 pp. (pp.P104, P110)Google Scholar
  37. 37.
    Greene FL et al., editors. (2002) AJCC Cancer Staging Manual. 6th ed., New York: Springer. 421 pp.Google Scholar
  38. 38.
    Eads CA et al. (2000) Methylight: A high-throughput assay to measure DNA methylation. Nucleic Acids Res. 28:E32.CrossRefGoogle Scholar
  39. 39.
    Chomczynski P, Sacchi N. (1987) Single-step method of rna isolation by acid guanidinium thiocyanate- phenol-chloroform extraction. Anal. Biochem. 162:156–9.CrossRefGoogle Scholar
  40. 40.
    Horikoshi T et al. (1992) Quantitation of thymidylate synthase, dihydrofolate reductase, and dt- diaphorase gene expression in human tumors using the polymerase chain reaction. Cancer Res. 52:108–16.PubMedGoogle Scholar
  41. 41.
    Kaplan EL, Meier P. (1958) Nonparametric estimation of incomplete observations. J. Am. Stat. Assoc. 53:457–81.CrossRefGoogle Scholar
  42. 42.
    Lee S, Hwang KS, Lee HJ, Kim JS, Kang GH. (2004) Aberrant cpg island hypermethylation of multiple genes in colorectal neoplasia. Lab. Invest. 84:884–93.CrossRefGoogle Scholar
  43. 43.
    Moragoda L, Jaszewski R, Kulkarni P, Majumdar AP. (2002) Age-associated loss of heterozygosity of tumor suppressor genes in the gastric mucosa of humans. Am. J. Physiol. Gastrointest. Liver Physiol. 282:G932–6.CrossRefGoogle Scholar
  44. 44.
    Kawakami K et al. (2006) DNA hypermethylation in the normal colonic mucosa of patients with colorectal cancer. Br. J. Cancer. 94:593–8.CrossRefGoogle Scholar
  45. 45.
    Gibson SL et al. (2003) Inhibition of colon tumor progression and angiogenesis by the Ink4a/Arf locus. Cancer Res. 63:742–6.PubMedGoogle Scholar
  46. 46.
    Jain RK. (2005) Normalization of tumor vasculature: An emerging concept in antiangiogenic therapy. Science. 307:58–62.CrossRefGoogle Scholar
  47. 47.
    McMahon G. (2000) Vegf receptor signaling in tumor angiogenesis. Oncologist. 5 Suppl 1:3–10.CrossRefGoogle Scholar
  48. 48.
    Baluk P et al. (2004) Regulated angiogenesis and vascular regression in mice overexpressing vascular endothelial growth factor in airways. Am. J. Pathol. 165:1071–85.CrossRefGoogle Scholar
  49. 49.
    Wang CH, Chang HC, Hung WC. (2006) p16 inhibits matrix metalloproteinase-2 expression via suppression of Sp1-mediated gene transcription. J. Cell Physiol. 208:246–52.CrossRefGoogle Scholar
  50. 50.
    Gloria L et al. (1996) DNA hypomethylation and proliferative activity are increased in the rectal mucosa of patients with long-standing ulcerative colitis. Cancer. 78:2300–6.CrossRefGoogle Scholar
  51. 51.
    Crott JW, Choi SW, Ordovas JM, Ditelberg JS, Mason JB. (2004) Effects of dietary folate and aging on gene expression in the colonic mucosa of rats: Implications for carcinogenesis. Carcinogenesis. 25:69–76.CrossRefGoogle Scholar
  52. 52.
    Kunimoto Y, Nakamura T, Ohno M, Kuroda Y. (2004) Relationship between immunohistochemical evaluation of thymidylate synthase and proliferating cell nuclear antigen labeling index in gastrointestinal carcinoma. Oncol. Rep. 12:1163–7.PubMedGoogle Scholar
  53. 53.
    Nakagawa T et al. (2004) Expression of thymidylate synthase is correlated with proliferative activity in non-small cell lung cancer (nsclc). Lung Cancer. 43:145–9.CrossRefGoogle Scholar
  54. 54.
    Cabibi D et al. (2007) Different expression of thymidylate synthase in primary tumor and metastatic nodes in breast cancer patients. Anticancer Res. 27:2227–30.PubMedGoogle Scholar
  55. 55.
    Wolters M, Strohle A, Hahn A. (2004) Age-associated changes in the metabolism of vitamin b(12) and folic acid: Prevalence, aetiopathogenesis and pathophysiological consequences [in German]. Z. Gerontol. Geriatr. 37:109–35.CrossRefGoogle Scholar
  56. 56.
    Jhaveri MS, Wagner C, Trepel JB. (2001) Impact of extracellular folate levels on global gene expression. Mol. Pharmacol. 60:1288–95.CrossRefGoogle Scholar
  57. 57.
    Iacopetta B et al. (2007) Methylation levels of line-1 repeats and cpg island loci are inversely related in normal colonic mucosa. Cancer Sci. 98:1454–60.CrossRefGoogle Scholar
  58. 58.
    Keyes MK et al. (2007) Older age and dietary folate are determinants of genomic and p16-specific DNA methylation in mouse colon. J. Nutr. 137:1713–7.CrossRefGoogle Scholar
  59. 59.
    James SJ et al. (2003) Mechanisms of DNA damage, DNA hypomethylation, and tumor progression in the folate/methyl-deficient rat model of hepatocarcinogenesis. J. Nutr. 133:3740–7S.CrossRefGoogle Scholar
  60. 60.
    Harada H et al. (1999) Restoration of wild-type p16 down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in human gliomas. Cancer Res. 59:3783–9.PubMedGoogle Scholar
  61. 61.
    Zambrano P et al. (2005) Aphase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes. BMC Cancer. 5:44.CrossRefGoogle Scholar
  62. 62.
    Arce C et al. (2006) A proof-of-principle study of epigenetic therapy added to neoadjuvant doxorubicin cyclophosphamide for locally advanced breast cancer. PLoS ONE. 1:e98.CrossRefGoogle Scholar

Copyright information

© Feinstein Institute for Medical Research 2008

Authors and Affiliations

  • Yvonne Wettergren
    • 1
  • Elisabeth Odin
    • 1
  • Staffan Nilsson
    • 2
  • Göran Carlsson
    • 1
  • Bengt Gustavsson
    • 1
  1. 1.Surgical-Oncology Laboratory, Department of General SurgeryGöteborg University, Plan 1, CK, Sahlgrenska University Hospital/ÖstraGöteborgSweden
  2. 2.Department of Mathematical StatisticsChalmers University of TechnologyGöteborgSweden

Personalised recommendations